HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of ...
Please provide your email address to receive an email when new articles are posted on . A novel pulsed field ablation technology successfully treated most patients with paroxysmal AF. The rate of ...
Pulse Biosciences’ nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting
Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation™ (nsPFA™) energy, today announced that its nPulse™ Cardiac Catheter will be ...
AI performed well in conducting preliminary readings of heart ultrasounds - Copyright AFP Fabrice COFFRINI AI performed well in conducting preliminary readings of ...
SCHAUMBURG - For the 14th year in a row, Pulse Technology has been selected for the Elite Dealer Award by ENX Magazine/The Week in Imaging, a national magazine that recognizes top technology and ...
Pulse Biosciences’ nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results